and quality of life? The answer is no: no one has ever demonstrated that a solidly fused 26 Ο thoracic curve is truly better than a solidly fused 36 Ο curve. The 10 Ο difference is merely a Cobb measurement of a singleplane radiograph, a classic example of the fallacy of looking at a single radiograph as an end-point of evaluation. This argument is strengthened by studies of the natural history of adolescent idiopathic scoliosis, especially those of Weinstein et al., 2 in which thoracic idiopathic curves of 36 Ο at the end of growth are quite benign. If a 36 Ο unfused thoracic scoliosis is benign, why is a 36 Ο fused thoracic scoliosis not a good result?
These issues also highlight the question of when treatment results should be analysed. If a 13-year-old girl with a 65
Ο thoracic scoliosis has a correction and fusion, and we analyse her results 2 years later at age 15, have we really analysed her results? No, she must confront adult life, be married, have children, and be a working person, before we truly analyse her outcome. 3 We are deeply indebted to the long-term outcome studies of Danielsson and Nachemson 4 of idiopathic scoliosis patients treated in Gothenburg, Sweden, 22 years previously. They compared the results for surgically treated patients, brace-treated patients, and a matched control group. The 90 age-and sex-matched controls were compared with 129 patients who had Harrington instrumentations and fusions, and 105 who had brace treatments. Similar numbers of patients in each group were married: 85% of the surgically and brace-treated patients, and an equivalent 82% of the Clinical research has made great progress in the last 20 years, particularly in the use of 'outcome analysis'. In the old days, a professor could publish the results of spinal fusion for scoliosis and simply state, "I did 150 spine fusions and got 140 solid, good results using my method".
This was accepted and widely repeated (if the professor was well-known). It did not, however, constitute adequate outcome analysis. Adequate outcome analysis requires that the patients' functional results be analysed-not just the radiological results. As Laing et al. 1 have pointed out, outcome research demands "end points emphasizing the patient's assessment of pain, function, quality of life, and satisfaction with the results of the intervention". It is not adequate to say that the patient's scoliosis was corrected from 65 Ο to 25 Ο ; we must also know whether the patient has pain or not, and what is his/her quality of life.
Some spinal deformity surgeons are prone to bragging that their scoliosis corrections are 60%, whereas other surgeons have achieved only a 45% correction. We must ask however whether this 15% difference is meaningful. To answer this question, a scientific study must be performed to show, with statistical significance, that the patient with a 60% correction has a better long-term outcome than the patient with a 45% correction.
Let us take the example of a patient with a 65 Ο thoracic curve who has a 60% correction to 26 Ο , versus the patient with a 65
Ο curve who has a 45% correction to 36
Ο . Has anyone ever demonstrated that a final result of 26 Ο is better than 36 Ο , analysing pain, function, control group. They produced 625 children, spread equally among the 3 groups. 22 years after treatment, low back pain was seen in 35% of the surgical group, 43% of the brace-treated group, and 28% of the control group (not significantly different). The vital capacity was the same in both the surgically and brace-treated groups, and the curve at follow-up was the same: 38 Ο . This clearly demonstrates that a patient with a
